dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Beà, Aida |
dc.contributor.author | Valero J.G. |
dc.contributor.author | Irazoki, Andrea |
dc.contributor.author | Lana, Carlos |
dc.contributor.author | López-Lluch, Guillermo |
dc.contributor.author | Portero-Otin, Manuel |
dc.contributor.author | Inserte Igual, Javier |
dc.contributor.author | Ruiz Meana, Marisol |
dc.date.accessioned | 2022-07-19T09:49:15Z |
dc.date.available | 2022-07-19T09:49:15Z |
dc.date.issued | 2022-05 |
dc.identifier.citation | Beà A, Valero JG, Irazoki A, Lana C, López-Lluch G, Portero-Otín M, et al. Cardiac fibroblasts display endurance to ischemia, high ROS control and elevated respiration regulated by the JAK2/STAT pathway. FEBS J. 2022;289(9):2540–61. |
dc.identifier.issn | 1742-4658 |
dc.identifier.uri | https://hdl.handle.net/11351/7812 |
dc.description | Fibroblasto cardiaco; Respiración celular; Supervivencia |
dc.language.iso | eng |
dc.publisher | Wiley |
dc.relation.ispartofseries | The FEBS Journal;289(9) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Sistema cardiovascular - Malalties |
dc.subject | Fibroblasts |
dc.subject.mesh | Cardiovascular Diseases |
dc.title | Cardiac fibroblasts display endurance to ischemia, high ROS control and elevated respiration regulated by the JAK2/STAT pathway |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1111/febs.16283 |
dc.subject.decs | enfermedades cardiovasculares |
dc.relation.publishversion | https://doi.org/10.1111/febs.16283 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Beà A, Lana C] Cell Signaling & Apoptosis Group, Institut de Recerca Biomedica de Lleida (IRBLleida), Universitat de Lleida, Spain. [Valero JG] Department of Hematology-Oncology, Institut d’Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. Centro de Investigacion Biomédica en Red-Oncología (CIBERONC), Barcelona, Spain. [Irazoki A] Departament de Bioquímica i Biomedicina Molecular, Facultat de Biologia, Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Universitat de Barcelona, Spain. [López-Lluch G] Andalusian Center of Developmental Biology, Pablo de Olavide University, Sevilla, Spain. Centro de Investigación Biomédica en Red Enfermedades Raras (CIBERER), Sevilla, Spain. [Portero-Otín M] Department of Experimental Medicine, IRBLleida, University of Lleida, Lleida, Spain. [Inserte J, Ruiz-Meana M] Laboratori de Cardiologia Experimental, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Spain. Centro de Investigación Biomédica en Red-CV (CIBER-CV), Barcelona, Spain |
dc.identifier.pmid | 34796659 |
dc.identifier.wos | 000723010200001 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2017-2020/PI19%2F01196 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |